The Phase Ib trial is set to test a gene therapy designed to target a rare disorder that causes muscle and respiratory failure.
The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have ...
Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...
The investigational advanced melanoma combination therapy consisting of RP1 and nivolumab have a PDUFA action date of July 22 ...
Replimune Group, Inc. REPL announced that the FDA has accepted the biologics license application (BLA) for its lead pipeline ...
In a Day 1 executive order, President Donald Trump withdrew from the landmark climate accord. Additional orders on energy are expected.
Privately owned Blue Origin has achieved its goal—a decade in the making—of becoming an orbital launch player, even as it ...
New to Kayo? Get your first month for just $1. Limited time offer. Appo, 25, has spent the past two seasons playing with the Bradford Bulls in the second-tier RFL Championship in the UK.